$262 Million is the total value of Wildcat Capital Management, LLC's 28 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 28.6% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CPNG | Buy | COUPANG INCcl a | $20,177,251 | +40.8% | 1,371,669 | +59.5% | 7.70% | +39.9% |
GLBE | Buy | GLOBAL E ONLINE LTD | $15,834,265 | -11.3% | 767,164 | +15.0% | 6.04% | -11.9% |
Z | Buy | ZILLOW GROUP INCcl c cap stk | $13,141,068 | +114.3% | 407,981 | +90.4% | 5.02% | +112.9% |
GWRE | Buy | GUIDEWIRE SOFTWARE INC | $9,004,136 | +87.8% | 143,928 | +84.9% | 3.44% | +86.6% |
MCO | New | MOODYS CORP | $8,915,840 | – | 32,000 | +100.0% | 3.40% | – |
Buy | EUROPEAN WAX CTR INC | $8,230,546 | +714.9% | 661,088 | +1107.6% | 3.14% | +709.8% | |
SNOW | Buy | SNOWFLAKE INCcl a | $3,244,722 | -15.5% | 22,605 | +0.0% | 1.24% | -16.1% |
DASH | Buy | DOORDASH INCcl a | $998,857 | +70.7% | 20,460 | +73.0% | 0.38% | +69.3% |
New | AKILI INC | $676,733 | – | 604,226 | +100.0% | 0.26% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-07
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
COSTAR GROUP INC | 32 | Q3 2022 | 48.3% |
UROGEN PHARMA LTD | 26 | Q3 2023 | 17.3% |
META PLATFORMS INC | 26 | Q3 2023 | 9.9% |
ALLOGENE THERAPEUTICS INC | 18 | Q3 2023 | 22.4% |
GOOSEHEAD INSURANCE INC -A | 18 | Q3 2023 | 15.4% |
SABINE RTY TRUST | 18 | Q3 2021 | 11.3% |
LPL FINL HLDGS INC | 18 | Q1 2019 | 12.7% |
PLAYA HOTELS & RESORTS NV | 18 | Q3 2021 | 3.4% |
NANTKWEST INC | 17 | Q3 2019 | 22.0% |
SORRENTO THERAPEUTICS INC | 17 | Q2 2019 | 7.0% |
View Wildcat Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Skillz Inc. | January 05, 2023 | 19,596,988 | 5.6% |
UroGen Pharma Ltd. | February 14, 2022 | 533,139 | 2.4% |
Skillz Inc. | March 08, 2021 | 21,832,022 | 7.5% |
NantKwest, Inc. | February 13, 2018 | 808,974 | 1.0% |
Sorrento Therapeutics, Inc. | February 13, 2018 | 1,738,232 | 2.2% |
View Wildcat Capital Management, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
3 | 2024-04-08 |
SC 13G | 2024-04-08 |
13F-HR | 2024-02-13 |
13F-HR | 2023-11-09 |
PX14A6G | 2023-11-03 |
13F-HR | 2023-08-11 |
13F-HR/A | 2023-08-10 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-07 |
SC 13D/A | 2023-01-05 |
View Wildcat Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.